Salarius Pharmaceuticals Inc (NAS:SLRX)
$ 1.67 0.0065 (0.39%) Market Cap: 2.41 Mil Enterprise Value: -558,000.00 PE Ratio: 0 PB Ratio: 0.82 GF Score: 29/100

Q4 2021 Salarius Pharmaceuticals Inc Earnings Call Transcript

Mar 10, 2022 / 10:00PM GMT
Release Date Price: $100 (+33.40%)
Operator

Good day and thank you for standing by. Welcome to Q4 2021 Salarius Pharmaceuticals Earnings Webcast and Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions).

I would now like to hand the conference over to Jason Rando of Tiberend Strategic Advisors. Please go ahead.

Jason Rando
Tiberend Strategic Advisors - Executive Vice President & Chief Operating Officer

Good afternoon and thank you for joining Salarius Pharmaceuticals' 2021 fourth quarter and full year financial and corporate results call. This afternoon, Salarius Pharmaceuticals issued a press release detailing its financial results for the three months and full year ended December 31, 2021, which we encourage listeners to read. The press release can be found in the News section of salariuspharma.com.

Before beginning today's call, I would like to make the following statement.

Today, we will be making certain forward-looking statements about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot